Your browser doesn't support javascript.
loading
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis.
Ryu, Changwan; Sun, Huanxing; Gulati, Mridu; Herazo-Maya, Jose D; Chen, Yonglin; Osafo-Addo, Awo; Brandsdorfer, Caitlin; Winkler, Julia; Blaul, Christina; Faunce, Jaden; Pan, Hongyi; Woolard, Tony; Tzouvelekis, Argyrios; Antin-Ozerkis, Danielle E; Puchalski, Jonathan T; Slade, Martin; Gonzalez, Anjelica L; Bogenhagen, Daniel F; Kirillov, Varvara; Feghali-Bostwick, Carol; Gibson, Kevin; Lindell, Kathleen; Herzog, Raimund I; Dela Cruz, Charles S; Mehal, Wajahat; Kaminski, Naftali; Herzog, Erica L; Trujillo, Glenda.
Afiliação
  • Ryu C; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Sun H; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Gulati M; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Herazo-Maya JD; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Chen Y; 2 Yale University School of Bioengineering, New Haven, Connecticut.
  • Osafo-Addo A; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Brandsdorfer C; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Winkler J; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Blaul C; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Faunce J; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Pan H; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Woolard T; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Tzouvelekis A; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Antin-Ozerkis DE; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Puchalski JT; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Slade M; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Gonzalez AL; 2 Yale University School of Bioengineering, New Haven, Connecticut.
  • Bogenhagen DF; 3 Department of Pharmacology and.
  • Kirillov V; 4 Department of Pathology, Stony Brook University School of Medicine, Stony Brook, New York.
  • Feghali-Bostwick C; 5 Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; and.
  • Gibson K; 6 Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Lindell K; 6 Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Herzog RI; 7 Section of Endocrinology and Metabolism, and.
  • Dela Cruz CS; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Mehal W; 8 Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut.
  • Kaminski N; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Herzog EL; 1 Section of Pulmonary, Critical Care, and Sleep Medicine.
  • Trujillo G; 4 Department of Pathology, Stony Brook University School of Medicine, Stony Brook, New York.
Am J Respir Crit Care Med ; 196(12): 1571-1581, 2017 12 15.
Article em En | MEDLINE | ID: mdl-28783377
ABSTRACT
RATIONALE Idiopathic pulmonary fibrosis (IPF) involves the accumulation of α-smooth muscle actin-expressing myofibroblasts arising from interactions with soluble mediators such as transforming growth factor-ß1 (TGF-ß1) and mechanical influences such as local tissue stiffness. Whereas IPF fibroblasts are enriched for aerobic glycolysis and innate immune receptor activation, innate immune ligands related to mitochondrial injury, such as extracellular mitochondrial DNA (mtDNA), have not been identified in IPF.

OBJECTIVES:

We aimed to define an association between mtDNA and fibroblast responses in IPF.

METHODS:

We evaluated the response of normal human lung fibroblasts (NHLFs) to stimulation with mtDNA and determined whether the glycolytic reprogramming that occurs in response to TGF-ß1 stimulation and direct contact with stiff substrates, and spontaneously in IPF fibroblasts, is associated with excessive levels of mtDNA. We measured mtDNA concentrations in bronchoalveolar lavage (BAL) from subjects with and without IPF, as well as in plasma samples from two longitudinal IPF cohorts and demographically matched control subjects. MEASUREMENTS AND MAIN

RESULTS:

Exposure to mtDNA augments α-smooth muscle actin expression in NHLFs. The metabolic changes in NHLFs that are induced by interactions with TGF-ß1 or stiff hydrogels are accompanied by the accumulation of extracellular mtDNA. These findings replicate the spontaneous phenotype of IPF fibroblasts. mtDNA concentrations are increased in IPF BAL and plasma, and in the latter compartment, they display robust associations with disease progression and reduced event-free survival.

CONCLUSIONS:

These findings demonstrate a previously unrecognized and highly novel connection between metabolic reprogramming, mtDNA, fibroblast activation, and clinical outcomes that provides new insight into IPF.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Fibrose Pulmonar Idiopática / Fibroblastos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Fibrose Pulmonar Idiopática / Fibroblastos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article